VTR sentiment intelligence

VENTAS INC : JEFFERIES RAISES TARGET PRICE TO $109 FROM $100

Jefferies has increased its target price for Ventas Inc. (VTR) shares to $109, up from the previous target of $100. This updated price target suggests a positive outlook from the analytical firm regarding Ventas Inc.'s future performance.

Tone

Positive 74/100

Event

Guidance

Published

15 Jul 2026 21:09

Source

Moomoo

Ventas (NYSE:VTR) Reaches New 1-Year High - Still a Buy?

Tone

Positive 66/100

Event

Market update

Published

15 Jul 2026 19:23

Source

MarketBeat

Jefferies Adjusts Price Target on Ventas to $109 From $100, Maintains Buy Rating

Tone

Positive 58/100

Event

Analyst action

Published

15 Jul 2026 14:35

Source

MT Newswires

Ventas stock reflects diversified healthcare real estate strategy

Ventas Inc. is a major US healthcare real estate investment trust (REIT) with a diversified portfolio spanning senior housing, medical offices, and life science properties. The company aims to generate long-term rental income by focusing on demographic aging and the rising demand

Tone

Positive 66/100

Event

Macro sensitivity

Published

15 Jul 2026 07:38

Source

Ad-hoc-news.de

Ventas stock reflects steady healthcare REIT positioning as senior housing demand grows

Ventas Inc. is a major healthcare REIT with a diversified portfolio spanning senior housing, medical office buildings, and life science research facilities across North America. The company's strategy is driven by an aging population, which supports long-term demand for healthcar

Tone

Positive 71/100

Event

Macro sensitivity

Published

14 Jul 2026 01:31

Source

Ad Hoc News

Ventas Inc. stock outperforms competitors on strong trading day

Ventas Inc. (VTR) shares rose 1.54% to $92.06 on Monday, performing strongly despite an overall poor trading session for the stock market, which saw the S&P 500 and Dow Jones Industrial Average fall. This increase broke a three-day losing streak for the company's stock.

Tone

Positive 71/100

Event

Market update

Published

13 Jul 2026 16:52

Source

MarketWatch

Ventas stock reflects steady healthcare real estate demand

Ventas Inc. (VTR) offers investors exposure to healthcare real estate, particularly senior housing and medical properties, with cash flow supported by long-term leases and aging demographics. The company operates as a REIT, distributing a significant portion of its taxable income

Tone

Positive 69/100

Event

Balance sheet

Published

13 Jul 2026 09:09

Source

Ad Hoc News

Commonwealth of Pennsylvania Public School Empls Retrmt SYS Boosts Stake in Ventas, Inc. $VTR

The Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its stake in Ventas, Inc. by 23.3% in the first quarter, now owning 323,545 shares worth approximately $26.46 million. Ventas reported mixed financial results with revenue above estimates but missed EPS, an

Tone

Positive 67/100

Event

Earnings

Published

13 Jul 2026 08:26

Source

MarketBeat

Candriam S.C.A. Boosts Holdings in Ventas, Inc. $VTR

Candriam S.C.A. significantly increased its stake in Ventas, Inc. (NYSE:VTR) by 163.2% in the first quarter, now owning 133,228 shares valued at $10,895,000. Several other institutional investors also adjusted their positions in the real estate investment trust, which has a curre

Tone

Positive 65/100

Event

Earnings

Published

13 Jul 2026 07:54

Source

MarketBeat

American Healthcare REIT (AHR) Proxy filing Summary

American Healthcare REIT (AHR) has published its proxy filing summary, detailing the upcoming annual meeting on June 24, 2026. Shareholders will vote on director elections, auditor ratification, and executive compensation. The company reported an 80% total shareholder return for

Tone

Positive 76/100

Event

Market update

Published

12 Jul 2026 00:39

Source

Quartr

BMO Capital Remains a Buy on Ventas (VTR)

BMO Capital analyst Juan C. Sanabria reiterated a Buy rating on Ventas (VTR) with a price target of $100.00. This follows Ventas's strong quarterly revenue of $1.66 billion and a net profit of $55.91 million. Corporate insider sentiment for VTR is positive, with an increase in in

Tone

Positive 73/100

Event

Analyst action

Published

11 Jul 2026 21:39

Source

The Globe and Mail

Azzad Asset Management Inc. ADV Invests $2.18 Million in Ventas, Inc. $VTR

Azzad Asset Management Inc. ADV has invested $2.18 million in Ventas, Inc. (NYSE:VTR) by purchasing 26,710 shares in the first quarter. Institutional ownership of Ventas remains high at 94.18%, with several brokerages raising their price targets and a consensus "Moderate Buy" rat

Tone

Positive 70/100

Event

Earnings

Published

11 Jul 2026 12:08

Source

MarketBeat

BMO Capital Maintains Ventas Inc(VTR.US) With Buy Rating, Maintains Target Price $100

BMO Capital has reiterated its Buy rating on Ventas Inc (VTR.US), a healthcare real estate investment trust. The firm has also maintained its target price for Ventas Inc at $100. This indicates BMO Capital's continued positive outlook on the company's stock performance.

Tone

Positive 72/100

Event

Analyst action

Published

11 Jul 2026 01:39

Source

Moomoo

Precision Trading with Ventas Inc. (VTR) Risk Zones

This article provides a detailed analysis of Ventas Inc. (VTR) by Stock Traders Daily, highlighting strong sentiment and a favorable risk-reward setup. It outlines three distinct AI-generated trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored for di

Tone

Positive 73/100

Event

Market update

Published

10 Jul 2026 19:38

Source

Stock Traders Daily

Resona Asset Management Co. Ltd. Has $24.64 Million Holdings in Ventas, Inc. $VTR

Resona Asset Management Co. Ltd. substantially increased its stake in Ventas, Inc. (NYSE:VTR) by 12.5% in the first quarter, now holding 301,720 shares valued at $24.64 million. Other major institutional investors like Vanguard Group Inc. and State Street Corp also boosted their

Tone

Positive 63/100

Event

Earnings

Published

10 Jul 2026 09:40

Source

MarketBeat

Ventas Inc. focuses on senior housing rebound as a healthcare REIT member of the S&P 500 index

Ventas Inc. is a healthcare real estate investment trust (REIT) and S&P 500 member that specializes in senior housing, medical office buildings, and life science properties. The company's strategy is driven by long-term demographic trends like an aging population and increasing d

Tone

Positive 73/100

Event

Market update

Published

09 Jul 2026 10:38

Source

Ad-hoc-news.de

American Healthcare REIT (AHR) Q1 2025 earnings summary

American Healthcare REIT (AHR) reported strong Q1 2025 results, with a sector-leading same-store NOI growth of 15.1% year-over-year, driven by its SHOP and ISHC/Trilogy segments. The company raised its full-year guidance for NOI and NFFO per share, while also outlining strategic

Tone

Positive 65/100

Event

Earnings

Published

09 Jul 2026 00:09

Source

Quartr

Ventas Inc focuses on senior housing recovery as US healthcare demand grows

Ventas Inc, a leading US healthcare real estate investment trust (REIT), is strategically focusing on the recovery of senior housing and medical office demand. The company's portfolio is designed to leverage demographic trends, particularly the aging US population, and maintain s

Tone

Positive 76/100

Event

Balance sheet

Published

08 Jul 2026 20:30

Source

AD HOC NEWS

Ventas Inc. focuses on senior housing and healthcare real estate

Ventas Inc. operates as a real estate investment trust (REIT) specializing in a diverse portfolio of senior housing and healthcare properties across North America. The company's strategy is driven by demographic trends, particularly the aging population, and aims for stable renta

Tone

Positive 71/100

Event

Market update

Published

08 Jul 2026 07:23

Source

AD HOC NEWS